Get started
Author

Per Magnusson

Observed names: P Magnusson, P. Magnusson
ORCID: 0000-0002-2123-7838
Observed ORCID: 0000-0002-2123-7838
OpenAlex ID: A5037484082
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
2017 · Mathias Haarhaus, Vincent Brandenburg, et al. · Nature Reviews Nephrology · 319
Bone Alkaline Phosphatase in CKD–Mineral Bone Disorder
2013 · Sunita Sardiwal, Per Magnusson, et al. · American Journal of Kidney Diseases · 146
Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease
2022 · Mathias Haarhaus, Giuseppe Cianciolo, et al. · Nutrients · 135
PDF
Bone alkaline phosphatase: An important biomarker in chronic kidney disease – mineral and bone disorder
2019 · Adrien Nizet, Etienne Cavalier, et al. · Clinica Chimica Acta · 127
Bone Alkaline Phosphatase and Tartrate-Resistant Acid Phosphatase: Potential Co-regulators of Bone Mineralization
2017 · Cecilia Halling Linder, Barbro Ek-Rylander, et al. · Calcified Tissue International · 127
PDF
Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms
2001 · Per Magnusson, Christopher A. Sharp, et al. · Kidney International · 124
Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy
2007 · Ann-Charlott Söderpalm, Per Magnusson, et al. · Neuromuscular Disorders · 123
Isoforms of Bone Alkaline Phosphatase: Characterization and Origin in Human Trabecular and Cortical Bone
1999 · Per Magnusson, Lasse Larsson, et al. · Journal of Bone and Mineral Research · 121
PDF
Serum Osteocalcin and Bone and Liver Alkaline Phosphatase Isoforms in Healthy Children and Adolescents
1995 · Per Magnusson, Anders Häger, et al. · Pediatric Research · 84
Common biochemical markers of bone turnover predict future bone loss: A 5-year follow-up study
2005 · Owe Löfman, Per Magnusson, et al. · Clinica Chimica Acta · 74
Different Responses of Bone Alkaline Phosphatase Isoforms During Recombinant Insulin-like Growth Factor-I (IGF-I) and During Growth Hormone Therapy in Adults with Growth Hormone Deficiency
1997 · Per Magnusson, Marie Degerblad, et al. · Journal of Bone and Mineral Research · 71
Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection
1992 · Per Magnusson, Owe Löfman, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 68
The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density
2020 · B. A. M. Larsson, L. Johansson, et al. · Osteoporosis International · 64
PDF
Serum Isoforms of Bone Alkaline Phosphatase Increase During Physical Exercise in Women
2000 · A. Rudberg, P. Magnusson, et al. · Calcified Tissue International · 63
Isozyme profile and tissue-origin of alkaline phosphatases in mouse serum
2013 · Cecilia Halling Linder, Ulrika H. Englund, et al. · Bone · 61
Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms
2009 · Cecilia Halling Linder, Sonoko Narisawa, et al. · Bone · 61
Diagnostic Approach to Abnormal Alkaline Phosphatase Value
2025 · Salvatore Minisola, Cristiana Cipriani, et al. · Mayo Clinic Proceedings · 59
PDF
Differences in Sialic Acid Residues Among Bone Alkaline Phosphatase Isoforms: A Physical, Biochemical, and Immunological Characterization
2002 · P. Magnusson, J.R. Farley · Calcified Tissue International · 59
Grade 1 Vertebral Fractures Identified by Densitometric Lateral Spine Imaging Predict Incident Major Osteoporotic Fracture Independently of Clinical Risk Factors and Bone Mineral Density in Older Women
2020 · Lisa Johansson, Daniel Sundh, et al. · Journal of Bone and Mineral Research · 55
PDF
Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts
2002 · Per Magnusson, Christopher A Sharp, et al. · Clinica Chimica Acta · 54
Serum Levels of Insulin-like Growth Factor Binding Proteins (IGFBP)–4 and –5 Correlate with Bone Mineral Density in Growth Hormone (GH)–Deficient Adults and Increase with GH Replacement Therapy
1998 · Marja Thorén, Agneta Hilding, et al. · Journal of Bone and Mineral Research · 53
PDF
Sclerostin: From Molecule to Clinical Biomarker
2022 · Ahmed Omran, Diana Atanasova, et al. · International Journal of Molecular Sciences · 48
PDF
Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain
1998 · Per Magnusson, Lasse Larsson, et al. · Clinical Chemistry · 46
Limosilactobacillus reuteri 6475 and Prevention of Early Postmenopausal Bone Loss: A Randomized Clinical Trial
2024 · Giulia Gregori, Aldina Pivodic, et al. · JAMA Network Open · 45
Bone Alkaline Phosphatase Isoforms in Hemodialysis Patients With Low Versus Non-Low Bone Turnover: A Diagnostic Test Study
2015 · Mathias Haarhaus, Marie-Claude Monier-Faugere, et al. · American Journal of Kidney Diseases · 44
Works count: 154
Citation count: 3,423
H-index: 32
I10-index: 78
Year
Topic
Type